Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Takepron Capsules 15/ Orally Dispersing (OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

NCT02099682 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02099682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02099682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Takepron Capsules 15/ Orally Dispersing (OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
January 31, 2014
Enrollment
3,366 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric or duodenal ulcers